1. Home
  2. KPTI vs EVTL Comparison

KPTI vs EVTL Comparison

Compare KPTI & EVTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KPTI
  • EVTL
  • Stock Information
  • Founded
  • KPTI 2008
  • EVTL 2016
  • Country
  • KPTI United States
  • EVTL United Kingdom
  • Employees
  • KPTI N/A
  • EVTL N/A
  • Industry
  • KPTI Biotechnology: Pharmaceutical Preparations
  • EVTL Aerospace
  • Sector
  • KPTI Health Care
  • EVTL Industrials
  • Exchange
  • KPTI Nasdaq
  • EVTL Nasdaq
  • Market Cap
  • KPTI 81.1M
  • EVTL 91.5M
  • IPO Year
  • KPTI 2013
  • EVTL N/A
  • Fundamental
  • Price
  • KPTI $0.63
  • EVTL $5.16
  • Analyst Decision
  • KPTI Strong Buy
  • EVTL Buy
  • Analyst Count
  • KPTI 4
  • EVTL 5
  • Target Price
  • KPTI $5.00
  • EVTL $10.13
  • AVG Volume (30 Days)
  • KPTI 678.9K
  • EVTL 699.8K
  • Earning Date
  • KPTI 02-27-2025
  • EVTL 03-13-2025
  • Dividend Yield
  • KPTI N/A
  • EVTL N/A
  • EPS Growth
  • KPTI N/A
  • EVTL N/A
  • EPS
  • KPTI N/A
  • EVTL N/A
  • Revenue
  • KPTI $148,442,000.00
  • EVTL N/A
  • Revenue This Year
  • KPTI $5.47
  • EVTL N/A
  • Revenue Next Year
  • KPTI $6.33
  • EVTL N/A
  • P/E Ratio
  • KPTI N/A
  • EVTL N/A
  • Revenue Growth
  • KPTI 1.77
  • EVTL N/A
  • 52 Week Low
  • KPTI $0.58
  • EVTL $3.55
  • 52 Week High
  • KPTI $1.70
  • EVTL $15.99
  • Technical
  • Relative Strength Index (RSI)
  • KPTI 46.51
  • EVTL 37.20
  • Support Level
  • KPTI $0.60
  • EVTL $4.71
  • Resistance Level
  • KPTI $0.70
  • EVTL $5.33
  • Average True Range (ATR)
  • KPTI 0.05
  • EVTL 0.62
  • MACD
  • KPTI -0.00
  • EVTL -0.22
  • Stochastic Oscillator
  • KPTI 46.61
  • EVTL 6.45

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.

About EVTL Vertical Aerospace Ltd.

Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a global aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero operating emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.

Share on Social Networks: